<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04597333</url>
  </required_header>
  <id_info>
    <org_study_id>0009-20-RMB</org_study_id>
    <nct_id>NCT04597333</nct_id>
  </id_info>
  <brief_title>Labor Induction After Failed Induction With Dinoprostone.</brief_title>
  <official_title>Comparison of Cervical Ripening Balloon Versus 2nd Dinoprostone Insert for Labor Induction in Women With a Failed 1st Attempt of Induction With Dinoprostone.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women after induction of labor with a dinoprostone insert will be evaluated after 24 hours&#xD;
      from the beginning of labor induction. Women with a BISHOP score of less than 5 will be&#xD;
      randomized to 1 of 2 groups. Induction with a cervical ripening balloon versus induction with&#xD;
      a 2nd dinoprostone insert.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nulliparous women with obstetric indications for induction of labor who were induced with a&#xD;
      dinoprostone insert and failed to go into labor after 24 hours from the beginning of labor&#xD;
      induction and a BISHOP score of less than 5 will receive a thorough explanation regarding the&#xD;
      study and sign informed consent. The eligible women will be randomized to 1 of 2 groups.&#xD;
      Induction with a cervical ripening balloon versus induction with a 2nd dinoprostone insert.&#xD;
      Relevant demographic and medical information will be gathered from the patients' electronic&#xD;
      files.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Actual">July 31, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delivery within 24 hours.</measure>
    <time_frame>From the time of induction up to 24 hours from induction.</time_frame>
    <description>Rate of delivery in 24 hours.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to delivery.</measure>
    <time_frame>From the time of induction up to 120 hours from induction.</time_frame>
    <description>The number of hours it takes to deliver.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mode of delivery.</measure>
    <time_frame>From the time of induction up to 120 hours from induction.</time_frame>
    <description>Vaginal and cesarean delivery rates.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uterine revision.</measure>
    <time_frame>From the time of induction up to 120 hours from induction.</time_frame>
    <description>The rate of uterine revision postpartum.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postpartum hemorrhage.</measure>
    <time_frame>From the time of induction up to 120 hours from induction.</time_frame>
    <description>The rate of postpartum hemorrhage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chorioamnionitis.</measure>
    <time_frame>From the time of induction up to 120 hours from induction.</time_frame>
    <description>The rate of chorioamnionitis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Induction of Labor Affected Fetus / Newborn</condition>
  <arm_group>
    <arm_group_label>2nd Dinoprostone.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women induced with a second dinoprostone insert.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cervical ripening balloon.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women induced with a cervical ripening balloon.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dinoprostone</intervention_name>
    <description>Dinoprostone vaginal insert.</description>
    <arm_group_label>2nd Dinoprostone.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cervical ripening balloon.</intervention_name>
    <description>Double lumen cervical ripening balloon.</description>
    <arm_group_label>Cervical ripening balloon.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women after induction of labor with Dinoprostone.&#xD;
&#xD;
          -  BISHOP score of under 5 after 1st induction attempt.&#xD;
&#xD;
          -  Nulliparous women.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women after induction of labor with a cervical ripening balloon.&#xD;
&#xD;
          -  BISHOP score of over 5 after 1st induction attempt.&#xD;
&#xD;
          -  Multiparous women.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roy Lauterbach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rambam health care campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>October 15, 2020</last_update_submitted>
  <last_update_submitted_qc>October 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>ROY LAUTERBACH MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dinoprostone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

